You are currently accessing this Site as a guest. Please login or register by clicking Here
Click here to see who are advancing transfusion alternatives and blood management.
Click here and see who are advancing transfusion alternatives and blood management.

Go Back   NoBlood > Resources > Medical Articles and Abstracts


Welcome to NoBlood.

You are currently accessing this Site as a guest which gives you limited access to most discussions and other features. By registering you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content and access many other special features. Registration is fast, simple and absolutely free so please, register today!

If you have any problems with the registration process or your account login, please contact contact us. If you forgot your password, click here to request a new one.

Tags: , , ,

Reply
 
LinkBack Thread Tools Rate Thread Display Modes
  #1 (permalink)  
Old 04-04-2005, 03:46 PM
Registered User
 
Join Date: Jan 2003
Posts: 1,422
Thanks: 0
Thanked 80 Times in 52 Posts
Jan B. Wade is on a distinguished road
An analysis of 55 patients concerning the significance of ductal and radial margins

Surgery. 2005 Apr;137(4):396-402..



Prognostic factors of surgical resection in middle and distal bile duct cancer: An analysis of 55 patients concerning the significance of ductal and radial margins.

Sakamoto Y, Kosuge T, Shimada K, Sano T, Ojima H, Yamamoto J, Yamasaki S, Takayama T, Makuuchi M.

Background The surgical outcome of middle and/or distal bile duct cancer remains unsatisfactory. Although the resectional margin is known to be a predictive factor, the prognostic significance of a positive ductal margin and other radial margin has never been evaluated independently. Methods The clinicopathologic data of 55 patients who had undergone surgical resection for middle and/or distal bile duct cancer between 1987 and 2003 were reviewed retrospectively. The surgical procedures consisted of pancreatoduodenectomy in 42 patients (76%), extrahepatic bile duct resection in 8 patients (15%), major hemihepatectomy (Hx) in 3 patients (5%), and pancreatoduodenectomy plus Hx in 2 patients (4%). In all the patients, intraoperative diagnosis of the ductal margins was performed using frozen sections. Twenty-one clinicopathologic factors, including the status of the ductal margins and of other radial margins, were evaluated using univariate and multivariate analyses. Results The overall 5-year survival rate and the median survival time were 24% and 38 months, respectively. There were 4 (7%) postoperative deaths. Fifteen of the remaining 51 patients (29%) were determined to have positive hepatic-side ductal margins during operation, and 14 of them underwent additional resection of the bile duct (1.6[range, 1-3] times, on average). As a result, hepatic-side ductal margin (hm) and duodenal-side ductal margin were found to be positive in 6 and 0 patients on the final pathologic analysis, respectively. Two of the 6 patients (33%) with positive hm have developed ductal recurrence so far, but the status of hm was not found to be a significant predictor. The depth of neoplastic invasion into the bile duct wall, pancreatic invasion, radial margin, and blood transfusion were significant prognostic factors by the univariate analysis. Multivariate analysis revealed that the depth of neoplastic invasion and blood transfusion were the independent prognostic factors. Conclusions In the treatment of middle and distal bile duct cancer, it is of importance to secure a negative radial margin, although it may be less beneficial to obtain a negative hm. Surgeons should make efforts to obtain negative radial margins and to avoid blood transfusion.
__________________
Mr. Jan B. Wade
Blood Management Consultant
Enhance Outcomes - Control Cost
For Information Call - 360 296-1807
Email
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
Reply

  NoBlood > Resources > Medical Articles and Abstracts



Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 
Thread Tools
Display Modes Rate This Thread
Rate This Thread:

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is On
Trackbacks are On
Pingbacks are On
Refbacks are On

Similar Threads
Thread Thread Starter Forum Replies Last Post
Value Chain Analysis For Blood Management: Issues & Opportunities Jan B. Wade Events 2 06-08-2007 08:24 AM
Analysis: New warnings on anemia drugs Jan B. Wade News and Hot Topics such as Hepatitis C, SARS and AIDS 3 03-12-2007 09:23 AM
Blood wasted during analysis Olio Ask a Professional 4 01-14-2007 05:58 AM
The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis Sharon Grant Medical Articles and Abstracts 0 10-20-2006 09:52 PM
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 st Sharon Grant Medical Articles and Abstracts 0 10-20-2006 08:59 PM


All times are GMT -7. The time now is 04:59 PM.






Featured
Hospital Sponsors
Hospitals Directory

Click here to help us make a difference today. Yes, for the price of a cup of coffee, you can help NoBlood continue its mission to advance knowledge and awareness of transfusion alternatives, blood conservation, blood management, bloodless medicine and bloodless surgery.
Please help us continue to make a difference today.

Highlights
Looking for help?
Can you help?

Key Wiki Articles
Register - FAQ - Members List - Calendar - Files - Videos - Mark Forums Read - NoBlood.org RSS Feeds

Powered by vBulletin® Version 3.6.10
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
SEO by vBSEO 3.1.0
Copyright © 1996 - 2008, Bloodless Healthcare International, Inc.